Jingjia Reports 2022 Revenue Growth and Industry Expansion

Apr.17.2023
Jingjia Reports 2022 Revenue Growth and Industry Expansion
Tobacco company JingJia's revenue increased in 2022, fueled by a growing e-cigarette industry and expanding international presence.

Recently, leading cigarette brand corporation Jinjia Group announced their 2022 annual report and board of directors' work report. The report indicates that in 2022, Jinjia Group achieved a revenue of ¥5.189 billion, with a YoY growth of 2.39%, and a net profit of ¥232 million, with a YoY drop of 78.02%.


A report has revealed that in 2022, Jinjia Corporation's revenue in the new tobacco industry will be 550 million yuan, a 223% increase compared to the previous year's revenue of 170 million yuan. This increase is attributed to the strong performance of the company's subsidiary, Jinjia Technology, which specializes in electronic cigarettes. In 2022, Jinjia Technology's revenue is projected to reach 230 million yuan, a 40% increase compared to last year's revenue of 160 million yuan. However, the company's net profit for 2022 is expected to be a loss of 7.3 million yuan, a 276% decrease from the net profit of 41.5 million yuan in 2021.


According to a report, Jingjia Co., Ltd. is expanding its industrial chain and establishing a comprehensive layout both domestically and overseas, in order to create a global electronic cigarette manufacturing enterprise and cultivate a well-known heated non-combustible pod brand.


Expansion of the New Tobacco Industry Chain:


An establishment of production base in Indonesia, around the research and development, manufacturing, branding, and overseas distribution of non-combustible tobacco heating products, aims to accelerate the market expansion in this sector. Additionally, a new e-cigarette logistics company called Yunpu Jiahang has been established, specializing in material management, international logistics, trade compliance and more. The company has already set up customs clearance channels in North America, the UK, Malaysia, New Zealand, and other regions. Investment has also been made in a heating equipment and e-liquid company called Jiadu Electronics, which seeks to expand brand operations, international expansion and operations, innovative product development, automated equipment, and scaled production in the new-style tobacco category.


It is understood that electronic cigarette brands under the company Jingjia Corporation include FOOGO and Lono. Currently, Lono has been sold in multiple markets including Russia, the Philippines, and Malaysia.


In terms of its packaging business (which is the main operation of Jinko Corporation), the company has recently developed new partnerships with electronic cigarette brands and corporate clients such as Imperial Tobacco, Philip Morris International, NJOY (the third largest e-cigarette brand in the United States), and Heyuan Technology.


In terms of domestic operations, several subsidiaries of the company's new tobacco industry chain have obtained licenses as tobacco monopoly production enterprises. They organize their production work according to the approved scope and quantity, providing main services to customers such as ODM/OEM services for new tobacco products including electronic cigarettes, as well as research, development, production and sales of vape oil, non-combustible heating fragrances and related supporting new materials.


Read More:


JingJia Corporation's subsidiary, Shenzhen Yunpu Xinghe, provides electronic cigarette export assembly services for domestic and international clients.


Jinjia Corporation reports that its electronic cigarette brand, Lono, has been sold in markets in Russia, the Philippines, and Malaysia.


JingJia Corporation's subsidiary companies, Wei Technology and JingJia Technology, failed to obtain the necessary tobacco monopolized production enterprise licenses.


Jiangjia Holdings predicts a net profit of 204-306 million yuan in 2022, a decrease of 70-80% compared to the previous year.


Jinjia Group expects to achieve a revenue of 554 million yuan from its new tobacco sector by 2022, which marks a year-on-year growth of 227.72%.


Reference source:


JinkoSolar Issues 2022 Annual Board of Directors Work Report.


Jingjia Corporation: Annual Financial Report for 2022



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Alimentation Couche-Tard said U.S. same-store sales in its “other nicotine products” category grew at a double-digit rate in the first quarter of fiscal 2027, led by nicotine pouches, while overall U.S. same-store merchandise revenues increased 1.7%. The company also said its Canadian nicotine business continued to face regulatory pressure and illicit-market headwinds. The U.S. performance coincides with Couche-Tard's participation in efforts to reopen Canadian convenience-store access to authorized nicotine pouches, though the company has not established a direct causal link between the two.
Sep.14
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Technology reported FY2026 revenue of about $96 million, down 24.7% year over year, as U.S. cannabis-vapor hardware and European e-cigarette sales declined by $17.4 million and $12.7 million, respectively. Fourth-quarter revenue rose 32.5% to $26.7 million, while quarterly gross margin fell to 6.3%. For FY2027, the company is prioritizing Malaysia manufacturing and vapor ODM while continuing to develop nicotine pouches, IKE Tech age-verification technology and G-Mesh licensing. Ispire has not separately disclosed the revenue or profit contribution of those newer businesses.
Regulations
Sep.17 by 2Firsts Perspectives
UK Directors Banned After 352,688 Vapes Imported From China Were Misdeclared as Medical Nebulizers in £15 Million Tax Case
UK Directors Banned After 352,688 Vapes Imported From China Were Misdeclared as Medical Nebulizers in £15 Million Tax Case
The UK Insolvency Service said YSK Enterprises imported large quantities of vapes from China in 2023, with a shipment addressed to the company declared as medical nebulizers before Border Force found 352,688 vaping products. HMRC calculated nearly £15 million ($20.3 million) in unpaid VAT and customs duty, alongside about £437,000 in corporation tax. Two directors were disqualified for nine years. The case predates the UK's Vaping Products Duty, which will introduce vape-specific excise and duty-stamp requirements from October 2026.
Regulations
Sep.11
Product | DOJO Launches BLAST10K Fresh in UK With 0+10ml E-Liquid Structure, Retaining 2+8ml Pod Compatibility
Product | DOJO Launches BLAST10K Fresh in UK With 0+10ml E-Liquid Structure, Retaining 2+8ml Pod Compatibility
DOJO launched the BLAST10K Fresh in the UK on September 4, 2026, introducing its INSTA-JUICED™ technology and a new 0+10ml structure that keeps e-liquid separated from the coil before activation. The device features a 1000mAh rechargeable battery, COREX BLAST dual-mesh technology and SSS leak-resistant technology, with a manufacturer-rated capacity of up to 10,000 puffs. It also retains compatibility with existing 2+8ml pods across the BLAST ecosystem. The launch introduces eight new flavors, including Matcha Strawberry, which DOJO describes as an industry first.
Market
Sep.04
California Lawmakers Pass Disposable Nicotine Vape Ban, With Sales Prohibition Set for 2028
California Lawmakers Pass Disposable Nicotine Vape Ban, With Sales Prohibition Set for 2028
According to CBS Los Angeles on August 27, 2026, California lawmakers have passed Assembly Bill 762, which would phase out disposable, battery-embedded nicotine vapes in the state. If signed by Governor Gavin Newsom, manufacturing and importation of the covered products would be prohibited beginning January 1, 2027, followed by a sales ban on January 1, 2028. Driven primarily by concerns over electronic waste, lithium-battery fires and environmental pollution, the legislation would further shift California’s legal vape market toward rechargeable, refillable or replaceable-pod devices.
Aug.28